Literature DB >> 1899637

Periarticular heterotopic ossification after total hip arthroplasty. Risk factors and consequences.

L Ahrengart1.   

Abstract

The formation of periarticular heterotopic bone after total hip arthroplasty is a frequent complication. The reported occurrences concerning this complication vary considerably in different reports, ranging from 15% to 90% with significant amounts in 1%-27% of the cases. Heterotopic ossification (HO) starts with the surgical operation, and the extent is well delineated on roentgenograms after six to 12 weeks. The amount of bone varies from small islands in the soft tissue to widespread bridging ossification. The cause of HO seems to be mainly related to systemic factors and is chiefly dependent on gender, diagnosis, and concurrent antiinflammatory medication. Patients at risk seem to be those with HO after a previous surgical operation, patients suffering from certain types of ankylosing spondylitis, otherwise healthy men with osteoarthrosis, patients with hypertrophic osteoarthrosis, and patients operated upon for fresh fractures or other posttraumatic conditions. The surgical technique and the local tissue trauma probably moderate both the occurrence and amount of HO. HO does not seem to cause pain or to decrease hip muscle strength but does limit hip mobility in cases with significant amount of ossification.

Entities:  

Mesh:

Year:  1991        PMID: 1899637

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  34 in total

1.  Developing a quantitative measurement system for assessing heterotopic ossification and monitoring the bioelectric metrics from electrically induced osseointegration in the residual limb of service members.

Authors:  Brad M Isaacson; Jeroen G Stinstra; Rob S MacLeod; Paul F Pasquina; Roy D Bloebaum
Journal:  Ann Biomed Eng       Date:  2010-05-11       Impact factor: 3.934

Review 2.  Prevention of heterotopic ossification after total hip replacement with NSAIDs.

Authors:  Roel Fijn; Rinco Th Koorevaar; Jacobus R Brouwers
Journal:  Pharm World Sci       Date:  2003-08

3.  Does a plastic drape reduce incidence of heterotopic ossification after hip resurfacing?

Authors:  John S Shields; Ali Mofidi; William G Ward; Riyaz H Jinnah
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

Review 4.  True trilineage haematopoiesis in excised heterotopic ossification from a laparotomy scar: report of a case and literature review.

Authors:  Theodoros Christofi; Dimitri A Raptis; Andreas Kallis; Faisal Ambasakoor
Journal:  Ann R Coll Surg Engl       Date:  2008-07       Impact factor: 1.891

5.  [Heterotopic ossifications in total hip arthroplasty: prophylaxis and therapy].

Authors:  J Schauwecker; F Pohlig; A Toepfer; H Gollwitzer; R von Eisenhart-Rothe
Journal:  Orthopade       Date:  2011-06       Impact factor: 1.087

Review 6.  Assessment and management of chronic pain in patients with stable total hip arthroplasty.

Authors:  Tim Classen; Daniela Zaps; Stefan Landgraeber; Xinning Li; Marcus Jäger
Journal:  Int Orthop       Date:  2012-11-23       Impact factor: 3.075

7.  Heterotopic bone formation about the hip undergoes endochondral ossification: a rabbit model.

Authors:  Oliver Tannous; Alec C Stall; Cullen Griffith; Christopher T Donaldson; Rudolph J Castellani; Vincent D Pellegrini
Journal:  Clin Orthop Relat Res       Date:  2013-01-30       Impact factor: 4.176

8.  Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients.

Authors:  Tim J Kruser; Kevin R Kozak; Donald M Cannon; Christopher S Platta; John P Heiner; Richard L Illgen
Journal:  J Arthroplasty       Date:  2012-01-14       Impact factor: 4.757

9.  Early Characterization of Blast-related Heterotopic Ossification in a Rat Model.

Authors:  Ammar T Qureshi; Erica K Crump; Gabriel J Pavey; Donald N Hope; Jonathan A Forsberg; Thomas A Davis
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

10.  Cationic Hyperbranched Polymers with Biocompatible Shells for siRNA Delivery.

Authors:  Sipei Li; Maiko Omi; Francis Cartieri; Dominik Konkolewicz; Gordon Mao; Haifeng Gao; Saadyah E Averick; Yuji Mishina; Krzysztof Matyjaszewski
Journal:  Biomacromolecules       Date:  2018-08-27       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.